NYU School of Medicine’s Proteomics Laboratory offers investigators specialized expertise for the analysis of proteins and peptides using mass spectrometry. Our laboratory continually develops new methods and customized approaches for proteomic analysis and suggests experimental strategies and sample preparation prior to mass spectrometry analysis.
We offer many different technologies, including the following:
- comprehensive protein identification
- analysis of affinity purified complexes
- characterizing protein post-translational modifications
- de novo sequencing
- label and label-free quantitation
- multiplexed quantitation
- global phosphorylation and ubiquitin analysis
- analysis of laser-capture microdissected formalin-fixed paraffin-embedded tissue
- secretome analysis
- crosslinking analysis
- disulfide mapping
Our laboratory is located at the Alexandria Center for Life Science in Manhattan, at 430 East 29th Street, 8th floor, room 860.
Alexandria Center for Life Science
430 East 29th Street, 8th Floor, Room 860
New York, NY 10016
How to Acknowledge the Proteomics Laboratory
The Proteomics Laboratory is subsidized in part by NYU School of Medicine and the Laura and Isaac Perlmutter Cancer Center support grant P30CA016087 from the National Cancer Institute (applicable only to principal investigators who are members of the Perlmutter Cancer Center). This support must be acknowledged in any publication or presentation resulting from data generated in the Proteomics Laboratory.
The laboratory also received a shared instrumentation grant from the National Institutes of Health (NIH) for the purchase of an Orbitrap Fusion™ Lumos™ Tribrid™ mass spectrometer. To support future grant funding, this grant must be acknowledged for any data acquired on this instrument.
We suggest the following language:
“The mass spectrometric experiments were supported in part by NYU School of Medicine.”
In addition, when applicable, use either of the following:
“Supported in part by NYU School of Medicine and the Laura and Isaac Perlmutter Cancer Center support grant P30CA016087 from the National Cancer Institute.”
“This work was supported by the NIH Shared Instrumentation Grant 1S10OD010582-01A1 for the purchase of an Orbitrap Fusion™ Lumos™ Tribrid™ mass spectrometer.”
Also, the NIH public access policy requires that all published work resulting from studies at our laboratory be accessible to the public through PubMed Central.